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Background: There is a paucity of data describing hospital-acquired infections (HAIs) in
Africa.
Objective: To describe the prevalence and distribution of HAIs in acute care hospitals in
Ghana.
Methods: Between September and December 2016, point-prevalence surveys were con-
ducted in participating hospitals using protocols of the European Centre for Disease Pre-
vention and Control. Medical records of eligible inpatients at or before 8am on the survey
date were reviewed to identify HAIs present at the time of the survey.
Findings: Ten hospitals were surveyed, representing 32.9% of all acute care beds in gov-
ernment hospitals. Of 2107 inpatients surveyed, 184 HAIs were identified among 172 pa-
tients, corresponding to an overall prevalence of 8.2%. The prevalence values in hospitals
ranged from 3.5% to 14.4%, with higher proportions of infections in secondary and tertiary
care facilities. The most common HAIs were surgical site infections (32.6%), bloodstream
infections (19.5%), urinary tract infections (18.5%) and respiratory tract infections (16.3%).
Device-associated infections accounted for 7.1% of HAIs. For 12.5% of HAIs, a micro-
organism was reported; the most commonly isolated micro-organism was Escherichia
coli. Approximately 61% of all patients surveyed were on antibiotics; 89.5% of patients
with an HAI received at least one antimicrobial agent on the survey date. The strongestt of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health
Accra, Ghana. Tel.: þ233 0548394763.
ahoo.com (N. Obeng-Nkrumah).
Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article
ivecommons.org/licenses/by-nc-nd/4.0/).
A-K. Labi et al. / Journal of Hospital Infection 101 (2019) 60e68 61independent predictors for HAI were the presence of an invasive device before onset of
infection and duration of hospital stay.
Conclusion: A low HAI burden was found compared with findings from other low- and
middle-income countries.
ª 2018 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Globally, hospital-acquired infections (HAIs) are the most
common adverse events to occur during hospitalization [1,2],
and are the cause of extended admissions, increased medical
costs, and marked morbidity and mortality [3e5]. Continued
improvements in patient safety depend on a comprehensive
understanding of the local epidemiology of HAIs. Reliable data
on HAIs is scarce in low-resource countries, and it is likely that
existing data underestimate the true burden [6]. Available data
describe an HAI prevalence rate of 15.5 per 100 patients in
developing countries [6]. In sub-Saharan Africa, these in-
fections are suspected to be widespread [1]. High rates of HAIs
persist due to lack of national infection prevention and control
(IPC) policies, lack of IPC personnel, and poor adherence to
existing HAI guidelines [1].
Elimination of HAIs is a priority of the Ministry of Health in
Ghana, as has been demonstrated recently by an update of the
IPC policy and guideline document [7]. The Ghana Health Ser-
vice emphasizes the importance of IPC through campaigns on
water, sanitation and hygiene. Despite these efforts, there is
currently no existing surveillance system to provide estimates
of the burden of HAIs across acute care patient populations in
Ghana. Themost recent estimate of HAI prevalence of 6.7% was
derived from a single-centre study published in 2009 [8]. To
address this knowledge gap, the authors conducted a large-
scale multi-centre HAI point-prevalence survey to determine
the prevalence and distribution of HAIs in acute care hospitals.
The findings provide a global picture of the epidemiological
situation in the country, and serve as a baseline for the eval-
uation of future IPC interventions in Ghana.Methods
Study design and settings
A country-wide point-prevalence study was conducted at 10
acute care hospitals, surveying all units/departments at each
facility. The hospitals were selected from 10 geographically
distinct regional health directorates in the country. In Ghana,
there are three teaching hospitals, 10 regional hospitals and
approximately 162 district hospitals [9,10]. The Ghana Health
Service reported a bed occupancy rate of 60.4% (N¼8195) for a
total bed capacity of 12,806 beds for all government hospitals in
2017 [9]. Representative samples of acute care hospitals were
drawn across Ghana (Figure 1) by applying systematic random
sampling to the national list of hospitals ranked according to
size and hospital type (teaching hospitals, regional hospitals
and district hospitals) as per the guidelines of the European
Centre for Disease Prevention and Control (ECDC) [11]. The
ECDC protocol provides a validated and standardized Europe-
wide consensus tool that can be implemented in settings withlimited network connectivity, and is thus suitable for use in
resource-constrained settings. Briefly, the hospital list for each
directorate was ranked in ascending order of the number of
beds. A sampling interval k was obtained by dividing the total
number of hospitals within each category by the number to be
sampled. One hospital was surveyed per directorate. A random
number i was selected between 1 and k. For each regional
health directorate, the ithþk hospital in the ascending order list
of hospitals was selected to constitute the survey site for that
region. The invitation for hospitals to participate in the survey
was sent to hospital directors in July 2016. Participation was
voluntary. The survey was conducted from 19th September to
2nd December 2016. The study was approved by the Ethical
Review Committee of the Ghana Health Service (GHS-ERC 08/
05/2016) and the Institutional Review Board of Korle-Bu
Teaching Hospital (KBTH-STC/IRB/00044/2016). Informed con-
sent was waived for the conduct of the study. Patients were de-
identified from study data to ensure anonymity. Arbitrary
numbers were allotted to all data assigned to the study.Patient selection
Inpatients of anyageadmittedandmonitored for>24h at the
included hospitals were eligible for inclusion in the study. Pa-
tients attending outpatient areas, accident and emergency de-
partments, thosewhohadbeenadmitted for<24h, and thoseon
rehabilitation units were excluded. The medical records of in-
patients at or before 8am on the survey date were reviewed by
the study teamwithin 12h. Forhospitalswith ahigh bedcapacity
(>1000), the total time frame for data collection on all wards of
a single hospital did not exceed one week.Data collection personnel and tools
Study information was collected manually on standardized
data forms. Two teams collected data from each hospital: a
primary team of research investigators from the HAI Ghana
research team and a secondary team of a selected group of
health professionals (members of the quality assurance or
infection control team) from each hospital. The secondary
teams were constituted to build the capacity of participating
hospitals to conduct future HAI prevalence surveys. The pri-
mary team reviewed medical records at each hospital, and
identified and collected information on patients who were
receiving antimicrobial agents for the treatment of active in-
fections or for no documented reasons using ECDC surveillance
definitions [11]. Data collected from the medical and nursing
records and other relevant charts were interpreted with the
help of attending physicians to determine whether patients
had an HAI. Medical records of patients that did not fulfil the
case definition for HAIs were reviewed by the secondary team
for data extraction. The secondary team received training in
Figure 1. Prevalence of hospital-acquired infection (HAI) across study hospitals categorized as primary, secondary and tertiary. The
width of the prevalence circle is proportional to the HAI burden. Number of beds not included in survey ¼ total of all inpatient beds
excluded from the survey based on inclusion/exclusion criteria plus all other vacant hospital beds.
A-K. Labi et al. / Journal of Hospital Infection 101 (2019) 60e6862conducting an HAI survey. Training sessions were concluded
with a pilot point-prevalence survey on selected hospital wards
to allow for remedial action. Standardized training packages
were developed and made available for use by participating
hospitals for future surveys. Data were collected on hospital
characteristics, including ward type and size, number of beds,
and number of patients admitted in each ward at the time of
the survey. Patient-based variables included age, sex, surgery
since admission, presence of indwelling devices, patients’
antimicrobial usage, presence of active HAI, results of routine
microbiological tests performed, and McCabe score. The
McCabe score categorizes the severity of underlying medical
conditions into non-fatal disease (expected survival of at least
five years), ultimately fatal disease (expected survival be-
tween one and five years), rapidly fatal disease (expected
death within one year) and unknown [11]. The specialty of the
main disease of the patient or of the consulting physician in
charge of the patient was captured as consultant specialty.
Case definitions
HAI was defined in accordance with ECDC guidelines [11].
An active infection was reported when signs and symptomswere evident on the survey date (with or without laboratory
results) and the patient was receiving corresponding anti-
biotic treatment. Patients were considered to be infected
even when signs and symptoms were no longer present but
the patient was still receiving treatment for that infection
on the survey date. In this case, the signs and symptoms
present from the start of antibiotic treatment until the
survey date were checked to verify whether an infection was
hospital acquired. An infection was considered to be hospital
acquired when the onset of the signs and symptoms occurred
>48 h after the current admission, or became apparent
within 48 h of admission but the patient had been discharged
from an acute care hospital <48 h before the current
admission [11]. For surgical site infections, the definition
included infections that occurred up to 30 days after surgical
intervention and affected either the incision or deep tissue
at the operating site, or infections related to an implant that
occurred within one year. Device-associated HAI was recor-
ded for urinary tract infections (urinary catheter in place
within seven days preceding HAI onset), bloodstream in-
fections (vascular catheter in place within 48 h before HAI
onset) and pneumonia (intubation within 48 h before HAI
onset).
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Figure 2. Distribution of hospital-acquired infection (HAI) prevalence by hospital type. The box shows interquartile range, horizontal line
in box shows median of the distribution, X denotes mean of distribution, lower whisker shows 25th percentile or lower quartile, upper
whisker shows 75th percentile or upper quartile. HAI prevalence: primary hospitals < secondary hospitals ¼ tertiary hospitals (Marascuilo
post hoc: overall Chi-squared¼11.44, P¼0.003). CI, confidence interval.
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Data were analysed using Access (Microsoft Corp., Red-
mond, WA, USA) and Statistical Package for Social Sciences
Version 21.0 (IBM Corp., Armonk, NY, USA). The point preva-
lence of HAIs was reported as the percentage of patients with
at least one HAI over the total number of patients. For
descriptive statistics, prevalence rates were calculated with
95% confidence intervals (95% CI), mean  standard deviation
(SD) or median with interquartile range (IQR), where appro-
priate. Univariate and multi-variate analyses were performed
to identify independent risk factors associated with HAIs. A
multi-variable logistic regression with linear or restricted cubic
splines was used to model the association between the pro-
portion of HAIs and duration of hospital stay before the day of
the survey.
Results
Data were collected from two teaching hospitals, three
regional hospitals and five district hospitals. Overall, 4208
acute care beds were included in this study, representing 32.9%
of the total bed capacity for government hospitals in Ghana.
Patient-based data were collected for a total of 2107 in-
patients, representing 50.1% of the total bed capacity of
participating hospitals.
Hospital and patient characteristics
Of the hospitals surveyed, five were primary, three were
secondary, two were tertiary, and none were specialized facil-
ities. Themedian bed size of the included hospitalswas 304 beds
(range 139e1533 beds). The overall bed occupancy rate was
59.1%. Only one of the participating hospitals had an infection
control nurse, and none of the participating hospitals had an
infection control doctor. There were no active surveillance
programmes on HAIs in any of the participating hospitals. The
median age of the patients surveyed was 26 years. This varied
from one day to 90 years (IQR 2e46 years). Males comprised
43.5% of all patients surveyed. The mean length of stay fromadmission until the survey date was 17.3 (SD 7.3) days (range
2.1e33.1 days;median 11 days; IQR 3.4e20.6 days). Themedian
length of stay of patients with HAI was six days (IQR 4e16 days)
until onset of infection, and 12.5 days (IQR 7e23 days) until the
survey date. The median length of stay until the survey date in
patients without HAI was three days (IQR 2e9 days).
Prevalence of HAIs
In total, 184 infections in 172 patients fulfilled the criteria of
HAI, corresponding to a point prevalence of 8.2% (N¼172/2107;
95% CI 7.1e9.4). Overall, 161 (93.6%) patients had one HAI. The
remaining 11 patients had multiple HAIs: 10 patients had two
HAIs and one patient had three HAIs on the survey date. The
prevalence of HAIs differed across hospitals (Figure 1) and
within each hospital category (Figure 2). Across tertiary hos-
pitals, the burden of HAIs was 9.2%, with a median ward
prevalence of 8.9% and IQR of 5.2e14.3%. A similar distribution
was observed in secondary hospitals: prevalence of HAIs, 9.5%;
median ward prevalence, 7.0%; and IQR, 4.7e14.8%. Primary
hospitals had a significantly lower prevalence of HAIs of 5.2%,
with a median ward prevalence of 2.1% and IQR of 1.1e5.4%.
The most frequently reported types of HAI were surgical site
infections (N¼60, 32.6%), bloodstream infections (N¼36,
19.5%), urinary tract infections (N¼34, 18.5%) and respiratory
tract infections (N¼30, 16.3%) (Table I). The prevalence of HAIs
was highest among patients admitted to surgical departments
(Figure 3), where 11.2% (N¼58/517) of patients had at least one
HAI compared with an average of 7.2% (N¼114/1590) for all
other specialties combined.
Device-associated HAIs and origin of infection
Hospital-acquired urinary tract infections were device
associated in 17.6% (N¼6/36) of all cases. Overall, 86.1%
(N¼31/36) and 13.8% (N¼5/36) of patients with bloodstream
infections had peripheral and central vascular catheters,
respectively, present in the 48 h preceding infection. The
bloodstream infections were secondary to another infection
site in 16.7% (N¼6/36) of cases [respiratory tract infection
Table I
Prevalence of hospital-acquired infection (HAI) by type among 2107 patients surveyed
HAI Prevalence among total HAIs Prevalence among total surveyed patients
Type Number % 95% CI % 95% CI
Surgical site infections 60 32.6 26.2e39.7 2.8 2.2e3.7
Bloodstream infections 36 19.5 14.5e25.9 1.7 1.2e2.7
Urinary tract infections 34 18.5 13.5e24.7 1.6 1.1e2.3
Respiratory tract infections 30 16.3 11.6e22.3 1.4 1.0e2.0
Others
Skin and soft tissue 10 5.4 3.0e9.7 0.5 0.3e0.9
Gastrointestinal infections 10 5.4 3.0e9.7 0.5 0.3e0.9
Ear, nose and throat 2 1.1 0.3e3.9 0.1 0.02e0.3
Central nervous system 1 0.5 0.09e3.0 0.1 0.01e0.3
Not specified 1 0.5 0.09e3.0 0.1 0.01e0.3
Total 184
CI, confidence interval.
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(N¼30/36) of bloodstream infections, the source of infection
was unknown. Of the HAIs identified, 159 (86.4%) were
related to the current hospital stay and occurred in 147
patients. The HAIs originated from another hospital facility in
25 (13.6%) cases, and were all present at the time of
admission. These included 10 (40%) surgical site infections,
six (24%) urinary tract infections, three (12%) respiratory
tract infections, three (12%) bloodstream infections, two
(8%) skin and soft tissue infections, and one (4%) gastroin-
testinal tract infection.0
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For 12.5% (N¼23/184) of HAIs, a micro-organism was re-
ported, ranging from 35.3% (N¼12/34) in urinary tract in-
fections, 10.0% (N¼6/60) in surgical site infections, and 11.1%
(N¼4/36) in bloodstream infections, to 1.9% (N¼1/54) in all the
other HAI types (Table II). The most frequently isolated micro-
organism from HAIs was Escherichia coli (N¼4/23). Meticillin
resistance was not reported in any of the Staphylococcus
aureus isolates with known susceptibility data. The majority,
84.6% (N¼11/13), of Enterobacteriaceae were resistant tod 
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Table II
Reported causative pathogens, according to type of infection
HAI pathogens UTI
(N¼34)
SSI
(N¼60)
BSI
(N¼36)
Others
(N¼54)
Reported antibiotic susceptibilitya
Gram-negatives
Acinetobacter spp. (N¼1) 0 0 1 0 Mer-S; Cip-S; Cot-R; Cef-R
Citrobacter spp. (N¼1) 1 0 0 0 Amk-S; Cip-R; Cef-R; Amo-clav-R
Klebsiella oxytoca (N¼1) 1 0 0 0 Mer-S; Amk-S; Cip-R; Cef-R, Amo-clav-R; Nit-S
Proteus mirabilis (N¼1) 1 0 0 0 Amk-S; Gen-S; Cip-R; Cxr-R; Cef-R; Tet-R
Other coliforms (N¼2) 0 2 0 0 Cip-S (N¼2/2); Lev-S (N¼2/2); Gen-R (N¼2/2);
Amk-S (N¼1/1); Chl-R (N¼1/1); Pip/Taz-R (N¼2/2);
Cef-R (N¼2/2)
Enterobacter spp. (N¼2) 1 1 0 0 Mer-R (N¼1/2); Amk-R (N¼1/1); Cip-R (N¼1/2);
Cxr-R (N¼1/1); Cef-R (N¼1/1)
Klebsiella spp. (N¼2) 2 0 0 0 Mer-R (N¼1/1); Amk-R (N¼1/1); Gen-R (N¼1/1);
Cip-R (N¼2/2); Cxr-R (N¼1/1); Lev-R (N¼1/1);
Pip/Taz-R (N¼1/1); Cot-R (N¼1/1); Cef-R (N¼2/2)
Pseudomonas aeruginosa (N¼2) 0 2 0 0 Amk-s (N¼2/2); Gen-R (N¼2/2); Cip-R (N¼2/2);
Lev-R (2/2); Cef-R (N¼1/2)
Escherichia coli (N¼4) 3 1 0 0 Amk-R (N¼3/4); Gen-S (N¼1/4); Cip-R (N¼2/2);
Lev-R (2/2); Cef-R (N¼2/3); Nit-S (N¼1/1);
Chl-R (N¼1/1); Cot-R (N¼1/1); Pip/Taz-R (N¼1/1)
Subtotal (N¼16) 9 (26.5) 6 (10.0) 1 (2.8) 0
Gram-positives
Enterococcus faecalis (N¼1) 1 0 0 0 Van-S; Amp-S; Lev-R
Enterococcus spp. (N¼1) 1 0 0 0 Van-S; Cip-R; Lev-R
Staphylococcus aureus (N¼1) 1 0 0 0 Ery-S; Gen-S; Chl-S; Tet-S; Cot-S.
Staphylococcus epidermidis (N¼2) 0 0 1 1 Cip-S (N¼2/2); Gen-R (N¼1/1); Chl-S; Tet-S
Streptococcus viridans (N¼2) 0 0 2 0 Pen-S ( N¼1/2); Cef-S (N¼1/1); Ery-R (N¼1/2);
Lev-R (N¼1/2); Van-S (N¼1/1)
Subtotal (N¼7) 3 (8.8) 0 3 (8.3) 1 (1.9)
Total (N¼23) 12 (35.3) 6 (10.0) 4 (11.1) 1 (1.9)
UTI, urinary tract infections; SSI, surgical site infections; BSI, bloodstream infections; others, respiratory tract infections, skin and soft tissue
infections apart from surgical site infections, central nervous system infections, gastrointestinal tract infections and unspecified infections; R,
resistant; S, susceptible; N, proportion of tested isolates that are susceptible or resistant to the indicated antibiotic; Mer, meropenem; Amk,
amikacin; Gen, gentamicin; Cip, ciprofloxacin; Pip/Taz, piperacillin/tazobactam; Pen, penicillin; Amp, ampicillin; Cef, cefotaxime; Cxr,
cefuroxime; Lev, levofloxacin; Van, vancomycin; Ery, erythromycin; Chl, chloramphenicol; Nit, nitrofurantoin; Cot, cotrimoxazole; Tet,
tetracycline.
a The antibiotic susceptibilities may not be generally representative with the very few isolates reported.
A-K. Labi et al. / Journal of Hospital Infection 101 (2019) 60e68 65third-generation cephalosporins. Two out of five Gram-
negative isolates tested were resistant to meropenem. Over-
all, 61.3% (N¼1291/2107) of the patients surveyed were
treated with antibiotics, whilst 89.5% (N¼154/172) of patients
with HAIs received at least one antimicrobial agent on the
survey date. Antibiotic use in patients without documented
HAIs was 58.8% (N¼1137/1934). In primary hospitals, 59.9%
(N¼402/671) of the surveyed patients were treated with anti-
biotics, compared with 76.5% (N¼317/494) and 60.8% (N¼572/
941) for secondary and tertiary hospitals, respectively. Data on
antibiotic prescription patterns and indications for use will be
published elsewhere.
Patient risk factors
The presence of a relevant invasive device prior to HAI onset,
and length of hospital stay 15 days were strongly associated
with HAI in the univariate analysis (Table A, see online
supplementary material). In the final multi-variate model, pa-
tients admitted to a primary care hospital were significantly less
likely to develop HAIs (Table III). The strongest independentpredictors for HAIs were the presence of a relevant invasive
device before onset of infection, and duration of hospital stay
before the survey date. The relationship between HAI and
duration of hospital stay was best described by linear spline
functions (Figure 4) incorporating three breakpoints at 6, 10 and
20 days of hospital admission. The adjusted odds ratios can be
interpreted as the odds of protection against HAI acquisition
decreasing at a rate of 4% from date of admission (day 0) to day
6, followed by increasing HAI levels at varying rates thereafter
(here, the odds of HAI acquisition increased by 9% from day
6e10, with a further 17% increase from days 10e20. The rate of
acquiring an HAI nearly doubles after day 20.Discussion
This paper represents the first multi-centre point-preva-
lence study of HAIs from Ghana, and includes data from pa-
tients at various levels of health service delivery in different
parts of the country. The overall prevalence of HAIs was 8.2%,
with the highest prevalence seen among surgical inpatients.
Table III
Multi-variable logistic regression analysisa of risk factors associated with hospital-acquired infection (HAI) in patients
Patient characteristics Level Adjusted odds ratio 95% confidence interval P-value
Duration of hospital stay before HAI onset 1 day 2.78 2.08e10.18 <0.001
Surgery since admission Yes/no 1.79 1.35e2.98 0.001
Presence of any invasive device Yes/no 5.03 4.77e13.35 0.001
Urinary catheter in place during hospitalization Yes/no 1.76 1.13e3.30 <0.001
Peripheral vascular catheter in place during hospitalization Yes/no 1.73 1.22e2.57 <0.001
Patient/consultant specialty (surgery) Yes/no 1.81 1.26e2.59 0.001
Admission to a primary care hospital Yes/no 0.37 0.33e0.71 0.010
a The predictive accuracy of the models evaluated by Hosmer and Lemeshow goodness-of-fit test was non-significant with P>0.05, suggesting that
themodel predicted accurately, on average. The discriminatory power of themultiple logistic regression analysis as measured by the area under the
receiver operating characteristic curve was 0.791. Stepwise modelling was adjusted for univariate variables with P<0.1.
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Figure 4. Changes in the odds of hospital-acquired infection (HAI) with length of hospital stay. Model is a linear spline function estimate
shown on the logit scale based on the least Akaike’s Information Criterion (Tables B and C, see online supplementary material).
A-K. Labi et al. / Journal of Hospital Infection 101 (2019) 60e6866The prevalence across the various hospitals ranged from 3.5%
to 14.4%, with a higher proportion of infections found in sec-
ondary and tertiary care facilities. These findings are compa-
rable to findings from other studies conducted in Africa, where
the overall prevalence of HAIs has been found to be between
2.5% and 14.8% [1,2], and studies from Europe, Brazil and
Vietnam with prevalence rates of 7.2%, 10.2% and 7.8%,
respectively [11e13]. A recent survey in Benin, however, re-
ported a prevalence of HAI of 19.1% [14]. The present study was
conducted using ECDC-approved methodology, and direct
comparison of the present results to other studies is hampered
by the differences in methodologies applied.
Surgical site, urinary tract and bloodstream infections were
the most common HAIs in this study. In the only previously re-
ported point-prevalence survey of HAIs in Ghana, surgical site
infections accounted for 39.3% of all HAIs [8]. In a recent survey
of abdominal surgery from the Tamale Teaching Hospital,
11.25% of all cases developed surgical site infections [15].
Surgical site infections represent a commonly reported HAI
worldwide, particularly in low-income countries, compared
with urinary tract and respiratory tract infections which pre-
dominate in high-income countries [16]. The higher prevalence
of surgical site infections may be due to inadequate pre-, peri-
and postoperative hygienic practices in low-resource settings.
In a recent study of air quality in operating theatres at a ter-
tiary care facility in Ghana, high levels of air contaminationwere detected, and this correlated with high rates of door
openings and number of people present during surgery [17].
High rates of surgical site infections may also be ascribed to
these infections being easier to recognize and diagnose in low-
resource settings compared with other HAIs [2]. However, in
the present study, the reported values for surgical site in-
fections may be understated as a proportion of surgical site
infections may occur after hospital discharge and may not have
been reported [2,18]. Recognition of surgical site infections
arising after hospital discharge would require setting up a
surveillance system that includes active follow-up. The rela-
tively high rates of surgical site infections reported in this study
highlights the need to improve safety in surgical practice across
hospitals in Ghana by implementing the new World Health Or-
ganization (WHO) guidelines for the prevention of surgical site
infections [19].
Among the patients surveyed, 61.3% were actively on anti-
biotics on the survey date, with higher rates of antibiotic use
observed in secondary and tertiary hospital facilities than pri-
mary hospitals. Antibiotic use among patients who had HAIs
(89.5%) was significantly higher compared with patients without
documented HAIs (58.8%). The authors did not collect adequate
clinical data to enable evaluation of whether antibiotic use was
justified based on clinical indication. However, the high rates
of antibiotic use are comparable with findings from countries
with similar developmental profiles [13,14], and could be
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in Ghana [20e22]. Low records of associated pathogens were
found among patients with HAIs. Notably, five of the hospitals
that participated in the study did not have infrastructure for
microbiological culture and antibiotic susceptibility testing. The
data may further represent low utilization of microbiological
diagnostics which may be linked with high out-of-pocket costs
associated with performance of these tests. Lack of information
regarding antibiotic susceptibility affects the selection of
appropriate agents for therapy, as well as implementation of
IPC precautions. Among 16 Gram-negative isolates reported,
widespread resistance was observed against commonly used
beta-lactam, aminoglycoside and quinolone antibiotics, and
two of the five isolates tested were resistant to meropenem
(Table II). Resistance appeared to be less common in Gram-
positive bacteria, but the low number of clinically relevant
isolates does not allow any firm interpretation of these data.
The findings should be interpreted with great caution as results
were drawn from local laboratories, and isolates were not
stored for confirmation by the study team. Nevertheless, the
findings are alarming and suggest widespread antimicrobial
resistance in Ghana, as reported elsewhere [21,23,24].
The risk of acquiring HAIs in this study was associated with
prolonged hospital stay. However, the risk of HAI was low for
patients admitted to primary hospital facilities compared with
secondary and tertiary hospital facilities. This could be
because secondary and tertiary facilities are more likely to
provide complex care to critically ill patients, with more
frequent use of devices such as central venous catheters and
artificial ventilators usually associated with the development
of HAIs. None of the hospitals enrolled in this study had an IPC
doctor, only one hospital had a full-time infection control
nurse, and none of the hospitals had an active infection control
team. Several of the hospitals made use of quality assurance
teams to perform the role of infection control teams. This state
of affairs persists despite the availability of a national IPC
policy document, which stipulates the implementation of all
the core components of infection prevention and control
[7,25]. Implementation of IPC activities is important to reduce
the burden of HAIs, and should be adapted to the local context
[26]. The standard at the surveyed hospitals is far from the
goals of the infection prevention guidelines, which recommend
one full-time infection control nurse per 100 beds in acute care
centres and per 150e205 beds in long-term care facilities [27]
or 250 beds as stipulated by WHO core component guidelines
[28]. It is instructive to note that improving the human resource
personnel for infection prevention has been outlined as a
global priority area [29].
This study has potential limitations. Although the hospitals
in this study represent different levels of hospital facilities,
they may not be representative of all healthcare facilities in
Ghana. The prevalence figures may be underestimated, as in-
fections that occur after discharge but may have originated
from hospitals were not taken into account. Also, the low rates
may have been affected by the relatively low bed occupancy
rate of 59% and the variable availability of microbiological
culture results. The findings are also based on folder review,
which is prone to poorly recorded or incomplete data as well as
absent information. A key strength of this study is that data
were actively collected using international standardized tools,
and validated by a set of trained individuals, leading to a
reduction in the variability in case definition and detection.In conclusion, this study found a prevalence of HAIs of 8.2%,
which is low compared with findings from other low- andmiddle-
incomecountries.Addressing theproblemofHAIs in low-resource
countriesmay require significant investment and commitment to
IPC, including training and deployment of infection control
healthcare professionals as an additional strategy to help
implement the numerous guidelines and recommendations.Acknowledgements
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